Dabur India has launched clinical trials to assess whether its flagship product Chyawanprash can boost immunity against the coronavirus. This is in line with the Ministry of Ayush's directive which issued self-care guidelines for preventive health measures and boosting immunity with special reference to respiratory health, amid the coronavirus pandemic.